Call for Papers

Submission Dates and Deadline

Free Paper and Poster Presentation submissions:
January 27, 2026 — March 31, 2026

Abstract Submission

Abstract submission is accepted exclusively through the online submission system.
To submit your abstract, please click the “Submit Your Abstract Here” button located at the bottom of this page and follow the instructions provided on the screen.
Please ensure that you have reviewed the information below before completing your submission.

＊Note

• Late submissions will not be considered.
• Currently we are preparing for an in-person, on-site meeting so we ask you to participate on-site.

Presentation Format and Abstract Categories

Style

• Oral Presentation
  Only computer-based presentations are allowed.
  (film slides and videotapes are not permitted)
• Poster Presentation
  Poster Viewing and Free discussions will take place in the Exhibition Hall.

Categories

Select an appropriate category from the following list.

＊Note

• The final decision of your presentation style will be made by the congress committee. Your choice may be changed to the other presentation style.
• During the abstract submission period, you may review, edit, or delete your submitted information by accessing the submission system.
• Please be aware that heavy traffic is expected on the submission system on the final day of the deadline, which may result in slow access or technical difficulties.
  To avoid any issues, presenters are strongly encouraged to complete their submission well in advance of the deadline.

Abstract Preparation Guidelines

Please prepare your abstract in accordance with the guidelines below.

• Word Limits
  Title: Up to 20 words
  Short Title: Up to 10 words
• Use of Abbreviations in Titles
  Abbreviations may be used in the title and short title, even at first mention.
  However, the full term followed by the abbreviation must be provided at its first occurrence in the abstract text.
• Abstract Body
  The abstract body must not exceed 300 words.
  Abstracts exceeding this limit will not be accepted.
• Abstract Structure
  Please structure the abstract using the following headings, in order:
  Purpose, Methods or Subjects, Results, and Conclusions.
  For case reports and similar submissions, the headings may be modified as appropriate.
  The Methods and Conclusion sections should be described clearly and in sufficient detail.
  Conclusions (or Discussions, if included) must be directly supported by the results presented.
• Use of Abbreviations in the Abstract
  All abbreviations should be spelled out at first mention, followed by the abbreviation in parentheses, for example:
  intraocular lens (IOL), medial rectus (MR).
  Widely accepted abbreviations such as DNA and RNA do not require definition.

Conflict of Interest

When making a presentation at The 2nd Asia-Pacific Pediatric Retina Association Meeting, the authors have to report any conflict of interest based on “the rules for conflict of interest of Japanese Ophthalmological Society.”
If the presentation is accepted, the category of conflict of interest and company names must be disclosed in the slide and poster for presentation, based on “the rules for conflict of interest of Japanese Ophthalmological Society.”

• Presentations to Which These Rules are Applicable
  These rules are applicable to all presentations, including those in Co-Sponsored Seminars, Special Lectures, Invited Lectures, Symposia, Instruction Courses, General Presentations (including posters), etc.,
• Report on Conflict of Interest at Abstract Submission
  Report the potential conflict of interest with companies within the last 3 years no matter whether it's concerned with or without the content of your presentation.
  If conflict of interest is “present,” enter the category, class and company names after each author's name in the entry field of “Conflict of Interest” on the abstract submission form.
  If conflict of interest is absent, enter “category N.” Confirm the declaration is correct prior to the registration.
  Categories and classes are as follows.

*Conflict of interest should be disclosed for the fiscal year during the previous threeyears when the author received the largest sum of money.

Disclosure in the Abstract and Slide

Abstract

The presence or absence of conflict of interest to be disclosed for the author (including co-authors) will be automatically shown at the end of the abstract, according to “the detailed rules of the standard for disclosure in the Japanese Ophthalmological Society.
“For categories F, C and R, only class IV (over 5,000,000 yen) will be correspond to “presence”.

Slide and poster

If the authors have to disclose any conflict of interest, the category and company names* should be described after the authors' names in the second slide and at the end of the poster.
For categories F, C and R, only class IV (over 5,000,000 yen) should be disclosed.

＊In the case of “Category P” (the author holds a patent or is in the process of applying for a patent), the company name need not to described.

＊If all authors do not have any conflict of interest to disclose, there will be a statement to the effect, “there is no conflict of interest to be disclosed”.

 Example of Disclosure of
Conflicts of Interest
［PowerPoint Example］

Abstract Submission

This system is supported on Google Chrome, Microsoft Edge, and Safari only.
Functionality on other browsers is not guaranteed.

＊Note
Please make any revisions or changes to your submission via the My Page link provided in your submission confirmation email.

Personal Information Protection

“Names” and “contact addresses” provided to us at registration for the meeting shall be used for the purpose of contact from the secretariat, notification of acceptance or rejection, and any information related to the presentation. In addition, the “presenters' names,” “affiliation names,” “title” and “abstract text” shall be used for publication in the program/proceedings and on the website, but not for other purposes. The registration process for applications has been commissioned to c/o Congrès Inc. in order to facilitate management operations.

Notification of Receipt of Abstracts

• For registration confirmation, notification will be sent to the registered e-mail address.
  If you do not receive notification at the registered e-mail address within 5 days, please inform the conference secretariat.
• For submissions (general presentations), notification of acceptance or rejection will be sent to the registered e-mail address by mid-April 2026 (tentative).

Contact

Congress Secretariat of
The 2nd Asia-Pacific
Pediatric Retina Association Meeting
c/o Congrès Inc.
E-mail: apprea2026@m.congre.co.jp
(Office hours: Weekdays 10:00 a.m. – 5:00 p.m. )
*Closed on Saturdays, Sundays, and public holidays